Solvent removal for kilo-scale preparative chromatography
The Rocket 4D Synergy uses proprietary vacuum technology to suppress solvent bumping and foaming.
The Rocket 4D Synergy evaporator from Genevac is designed to provide a productive tool for automatic drying or concentration of very large volumes.
Configured with a 5-L 316 stainless steel evaporation vessel, the Rocket Synergy 4D is proven to offer productive automated removal of solvent for labs running kilo-scale preparative chromatography equipment.
Traditionally, such labs have relied upon using several rotary evaporators to remove the large volumes of solvent from sample fractions. This time consuming manual process requires a dedicated operator to top-up dry ice in cold traps, feed the systems with more product and watch the systems continually. With a Rocket 4D Synergy evaporator, users simply load their sample, select a method, press start, and walk away, leaving the system to do the rest.
The compact Rocket 4D Synergy allows users to dry or concentrate samples with complete confidence as it uses proprietary vacuum technology to suppress solvent bumping and foaming – problems associated with sample loss when using large scale rotary evaporators.
Users wishing to dry volumes larger than 5 L require the ‘Autofeed’ option, which enables the Rocket 4D Synergy to automatically draw in further chromatographic eluent ready for evaporation. The Rocket 4D Synergy controls product feed, drying and the discharge of condensed waste solvent without any external intervention. The autofeed system has an integrated rinse circuit which enables dried products to be automatically re-dissolved in a small volume of solvent at the end of the process.
Alternatively, the same circuit can be used under manual control for solvent exchange, by selecting a different solvent for re-dissolve. Cleaning the Rocket 4D Synergy between cycles is very straightforward. The PTFE feed tubing is easily detached for cleaning or replacement and the vessel can be readily cleaned, wiped, inspected and even put in a dishwasher. The Rocket 4D Synergy also includes powerful cold traps that maximise solvent recovery protecting the environment and improving drying of samples.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance